Skip to main content
. Author manuscript; available in PMC: 2021 Mar 22.
Published in final edited form as: Lancet Haematol. 2019 Dec 23;7(3):e238–e246. doi: 10.1016/S2352-3026(19)30206-6

Figure 2: Overall Survival of patients with Shwachman Diamond syndrome by complex karyotype and bone marrow surveillance status.

Figure 2:

Figure 2:

A) Kaplan-Meyer curves depicting overall survival of patients with SDS and MDS according to complex karyotype (orange) or without a complex karytoype (blue) at initial diagnosis of MDS with 95% confidence intervals (shaded areas). B). Kaplan-Meyer curves depicting overall survival of patients with SDS and MDS or AML according to bone marrow surveillance status. Subjects who had received bone marow surveillance prior to diagnosis of MDS or AML (orange) are compared to those without surveillance prior to diagnosis (blue) with 95% confidence intervals (shaded areas).